Abstract
To assess the effect of ivermectin on the morbidity caused by hookworm-related cutaneous larva migrans in patients in hyperendemic areas, we treated 92 patients (with 441 tracks in total) from Manaus, Brazil, with single-dose ivermectin (200 µg/kg). Four weeks later, patients had 60 tracks, and the associated morbidity improved significantly.
Keywords:
Brazil; HrCLM; clinical pathology; endemic area; ivermectin.
Publication types
-
Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Animals
-
Antiparasitic Agents / administration & dosage*
-
Brazil / epidemiology
-
Chi-Square Distribution
-
Child
-
Child, Preschool
-
Endemic Diseases
-
Female
-
Hookworm Infections / drug therapy*
-
Hookworm Infections / epidemiology
-
Hookworm Infections / parasitology
-
Humans
-
Ivermectin / administration & dosage*
-
Larva Migrans / drug therapy*
-
Larva Migrans / epidemiology
-
Larva Migrans / parasitology
-
Male
-
Middle Aged
-
Young Adult
Substances
-
Antiparasitic Agents
-
Ivermectin